Epizyme (EPZM) PT Lowered to $29 at Citi
Tweet
Share
E-mailGet Alerts EPZM Hot Sheet
Price: $1.47 --0%
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Citi analyst Robyn Karnauskas lowered the price target on Epizyme (NASDAQ: EPZM) to $29.00 (from $30.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts TJX Companies rating to Neutral, lowers price target
- Breville Group Ltd. (BRG:AU) (BVILF) PT Lowered to AUD34.30 at JPMorgan
- Evolution Mining Ltd. (EVN:AU) (CAHPF) PT Raised to AUD14.50 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
